Page last updated: 2024-11-06

benzimidazole and Central Nervous System Diseases

benzimidazole has been researched along with Central Nervous System Diseases in 1 studies

1H-benzimidazole : The 1H-tautomer of benzimidazole.

Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.

Research Excerpts

ExcerptRelevanceReference
"Their anti-HPNS properties, like those previously established for the mephenesin group of centrally acting muscle relaxants, seem to be related to their ability to antagonize the convulsive action of strychnine."1.27Effect of benzazole-related centrally acting muscle relaxants on HPNS. ( Bowser-Riley, F; Daniels, S; Smith, EB, 1988)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bowser-Riley, F1
Daniels, S1
Smith, EB1

Other Studies

1 other study available for benzimidazole and Central Nervous System Diseases

ArticleYear
Effect of benzazole-related centrally acting muscle relaxants on HPNS.
    Undersea biomedical research, 1988, Volume: 15, Issue:5

    Topics: Animals; Benzimidazoles; Central Nervous System Diseases; Chlorzoxazone; High Pressure Neurological

1988